Yung Sheng Biotech Co., Ltd.
永笙生技股份有限公司 romanised, not a registered English name
Leave your email for change alerts (optional)
2013Founded
NT$2.2BPaid-in capital
0Plants
1Certifications
NT$100–500MRevenue band
- Unified Business No.
- 60085392
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Listed (TWSE) (1,087) 4178
- Founded
- 2013-06-26
- Paid-in capital
- NT$ 2,158,669,810
- Phone
- (02)2601-3013
- Website
- https://stemcytebio.com/
- Annual revenue band
- NT$100–500M
- Growth & profitability
- Revenue 2026-09 YoY +28.2%, year-to-date +2.7%
Gross margin 31%, operating margin -60.9%, net margin -47.8% (2026-Q2 YTD)
Certifications 1
- FDA (53)Self-reported
Processes & materials 1
- Biotechnology (664) · Company nameSelf-reported
Similar companies 10
- OBI PHARMA, INC. Listed (TPEx) NT$20–100M
Shared: Biotechnology, FDA - Han Kang Biotech Co. (Cayman) Listed (TWSE) NT$20–100M
Shared: Biotechnology - Chuan Yu Biotech Holdings Co., Ltd. Listed (TWSE) NT$1–5B
Shared: Biotechnology - PHARMAENGINE, INC. Listed (TPEx) NT$1–5B
Shared: Biotechnology, FDA - TLC BioSciences Corp. Emerging stock (TPEx) NT$20–100M
Shared: FDA - ALAR PHARMACEUTICALS INC. Listed (TPEx) < NT$20M
Shared: Biotechnology, FDA - Kuang Li Biotech Holdings Co., Ltd. Listed (TWSE) NT$100–500M
Shared: Biotechnology - ANBOGEN THERAPEUTICS, INC. Emerging stock (TPEx) < NT$20M estimated
Shared: Biotechnology - AP BIOSCIENCES INC. Listed (TPEx) < NT$20M estimated
Shared: Biotechnology - CHO PHARMA INC. Emerging stock (TPEx) < NT$20M
Shared: FDA